TRIB Stock - Trinity Biotech plc
Unlock GoAI Insights for TRIB
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $61.55M | $56.83M | $62.52M | $81.15M | $101.98M |
| Gross Profit | $21.44M | $19.45M | $22.05M | $33.45M | $48.58M |
| Gross Margin | 34.8% | 34.2% | 35.3% | 41.2% | 47.6% |
| Operating Income | $-21,165,000 | $-27,045,000 | $-15,269,000 | $3.94M | $82,000 |
| Net Income | $-31,789,000 | $-24,018,000 | $-41,002,000 | $875,000 | $-6,388,000 |
| Net Margin | -51.6% | -42.3% | -65.6% | 1.1% | -6.3% |
| EPS | $-1.77 | $-3.20 | $-6.00 | $0.21 | $-1.54 |
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.
Visit WebsiteEarnings History & Surprises
TRIBEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 3, 2026 | — | — | — | — |
Q4 2025 | Dec 26, 2025 | $-1.48 | — | — | — |
Q4 2025 | Dec 19, 2025 | $-1.48 | — | — | — |
Q3 2025 | Jul 1, 2025 | $-0.28 | $-2.40 | -757.1% | ✗ MISS |
Q2 2025 | May 15, 2025 | $-0.30 | $-1.02 | -240.0% | ✗ MISS |
Q1 2025 | Jan 29, 2025 | $-0.54 | $-0.06 | +88.9% | ✓ BEAT |
Q4 2024 | Nov 15, 2024 | $-0.54 | $-0.43 | +20.4% | ✓ BEAT |
Q4 2024 | Oct 1, 2024 | $-0.65 | $1.00 | +253.8% | ✓ BEAT |
Q2 2024 | May 23, 2024 | $-3.00 | $-0.37 | +87.7% | ✓ BEAT |
Q2 2024 | Apr 4, 2024 | $-3.50 | $-0.68 | +80.6% | ✓ BEAT |
Q4 2023 | Oct 3, 2023 | $-0.09 | $-1.00 | -1011.1% | ✗ MISS |
Q3 2023 | Sep 6, 2023 | — | $-0.06 | — | — |
Q3 2023 | Jul 6, 2023 | $-0.06 | $-0.80 | -1233.3% | ✗ MISS |
Q1 2023 | Mar 23, 2023 | $-0.06 | $-0.90 | -1400.0% | ✗ MISS |
Q4 2022 | Dec 15, 2022 | $-0.20 | $-0.90 | -350.0% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | $-0.20 | $-0.40 | -100.0% | ✗ MISS |
Q2 2022 | Apr 11, 2022 | $0.07 | $0.30 | +328.6% | ✓ BEAT |
Q4 2021 | Dec 31, 2021 | — | $0.02 | — | — |
Q4 2021 | Dec 15, 2021 | — | $0.45 | — | — |
Q3 2021 | Sep 9, 2021 | $0.07 | $1.00 | +1328.6% | ✓ BEAT |
Latest News
Trinity Biotech Expands Global Rollout Of Next-Generation HbA1c Column System
📈 PositiveTrinity Biotech Receives WHO Approval For Offshored And Outsourced Upstream Manufacturing Activities Of Uni-Gold HIV Rapid Test
📈 PositiveTrinity Biotech Partners With Unnamed Bioinformatics Firm To Conduct Analysts On Clinical Study Data For EpiCapture Epigenetic Liquid Biopsy Test To Monitor Prostate Cancer
📈 PositiveTrinity Biotech Says Welcomes Intention Of Perceptive Advisor's Indication Of A Potential Debt-to-Equity Conversion
📈 PositiveTrinity Biotech Regains Nasdaq Compliance
📈 PositiveTrinity Biotech shares are trading higher after the company was granted regulatory approval for offshored and outsourced manufacturing of its flagship rapid HIV test.
📈 PositiveTrinity Biotech Granted Regulatory Approval For Offshored And Outsourced Manufacturing Of Its Flagship Rapid HIV Test
📈 PositiveFrequently Asked Questions about TRIB
What is TRIB's current stock price?
What is the analyst price target for TRIB?
What sector is Trinity Biotech plc in?
What is TRIB's market cap?
Does TRIB pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to TRIB for comparison